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ABSTRACT  
Aim: To compare the effect of Baladi Ghrita Nasya with Goghrita Nasya in the management of Nasapratinaha. 
Objective: 1. To evaluate the effect of Baladi Ghrita (trail drug) Nasya in management of Nasapratinaha. 
2. To evaluate the effect of Nasya with Goghrita (control drug) in management of Nasapratinaha. 
Method: Patients were divided into 2 groups. i.e., Group A and Group B. 
Group A - Baladi Ghrita Nasya was administered for seven days, once daily in the morning.  
Group B- Nasya with Goghrita for seven days was administered, once daily in the morning. 
Types of study: Comparative Clinical Study. 
Period of Study: After seven days of treatment, both the groups were followed at regular intervals of 15 days 
for a period of two months. 
Follow Up: Both the groups were followed at regular intervals of 15 days. 
Results: By comparing both the groups, Group A patients those who were administered Baladi Ghrita Nasya 
showed a significant improvement / relief in the management of Nasapratinaha.  
Statistical Analysis: The Statistical Analysis reveals that In Nasapratinaha the efficacy of treatment with 
Baladi Ghrita Nasya has an effective role in treating Nasapratinaha than Nasya with plain Goghrita. 
Conclusion: In Nasapratinaha the efficacy of treatment with Baladi Ghrita Nasya has an effective role in 
treating Nasapratinaha than Nasya with plain Goghrita. 
KEYWORDS: Nasapratinaha, Baladi Ghrita Nasya, Goghrita Nasya. 
INTRODUCTION
Shalakya Tantra comprises the study of 
diseases affecting the organs situated above jatru 
(clavicle) and their treatment. Nasa is a part situated 
above the Jatru. Therefore the study of Nasarogas and 
their treatment are included in Shalakya Tantra. Our 
classics have explained 31 types of Nasarogas of which 
Nasapratinaha is one. It is one of the common clinical 
conditions found in day to day general as well as 
Shalakya practice. It presents with obstruction of nose 
as its cardinal feature and its occurrence is found in 
both sexes and in all age groups. 
The cardinal feature of Nasapratinaha is nasal 
obstruction. This condition is becoming increasingly 
prevalent because of few common Nidana encountered 
nowadays such as Avashyaya (fog), Rajo (dust), Dhuma 
(smoke), Asathyma Gandha (smell) and Vayu Sevana 
etc. Hence the incidence of Nasapratinaha is becoming 
more prevalent among the population. In this regard 
while exploring Ayurvedic Classics, we come across few 
simple techniques and principles in the treatment of 
Nasapratinaha, of which, Nasya with Baladi Ghrita is 
one. Nasya karma is considered as a prime treatment 
modality in all types of Nasaroga and also in 
Nasapratinaha. 
Ashtanga Sangraha has described ‘Baladi 
Ghrita Nasya’ in diseases of Urdhwa Jatru where there is 
predominance of Vata Dosha. This technique is easy to 
perform and the medicines are easily available and 
economical. Hence, it is selected for the present 
research work in Nasapratinaha. This work is intended 
to know the efficacy of the trial drug. For this purpose, a 
need for the control group was taught either with a 
placebo or with a standard drug. 
There are various references regarding the 
usage of Goghrita as a base for different Nasya Yogas 
used in the management of Nasapratinaha. Goghrita is 
said to possess qualities like Deepana etc. Because of 
this reasons, Goghrita has been taken for the 
comparison as a control drug in this study. In the 
present clinical study patients are divided into 2 groups 
with 10 patients in each group. ‘Group A’ is 
Mayur V.Shiralkar et al. Comparative Study of Baladi Ghrita Nasya with Goghrita Nasya in the Management of Nasapratinaha 
 Available online at : http://ijapr.in  78 
administered with Baladi Ghrita Nasya; and ‘Group B’ 
Nasya with Goghrita is administered to evaluate the 
effect of Baladi Ghrita Nasya in the management of 
Nasapratinaha. 
The entire study contains the contents like of 
review of literature, which has the literary aspects of 
both Ayurvedic and contemporary science. It deals 
Nirukti, Paribhasha, Nidana Panchaka, Sadyasadhyata, 
Chikitsa, review on Nasya and drug review. The 
chapters concerning the clinical trials are materials and 
methods, observations and results, discussion and 
conclusion. 
Aims & Objectives  
Aims: To compare the effect of Baladi Ghrita Nasya 
with Goghrita Nasya in the management of 
Nasapratinaha. 
Objectives 
1. To evaluate the effect of Baladi Ghrita (trail drug) 
Nasya in management of Nasapratinaha. 
2. To evaluate the effect of Nasya with Goghrita 
(control drug) in management of Nasapratinaha. 
Materials and Methods 
Materials 
The drugs/formulation taken for the study are: 1.Baladi 
Ghrita Nasya 2.Goghrita  
I. Baladi Ghrita Nasya 
The ingredients of Baladi Ghrita Nasya are Bala and 
Bilva moola which was used for Nasya karma in Group 
A.  
II. Goghrita 
Ghrita Prepared from Cow’s milk was used for of Nasya 
karma in Group B. 
Collection of Drugs 
 All the raw materials were procured and 
purchased from reliable Ayurvedic Raw Material 
shop.  
 Goghrita was procured from a reliable milk 
vender.  
Method of preparation of Baladi Ghrita Nasya: 
Baladi Ghrita Nasya was freshly prepared in the 
Shalakya Kriya kalpa room of S.D.M. Ayurvedic Hospital, 
Hassan.  
Equal quantity of Bala Moola Choorna and Bilva 
Moola Choorna were taken. Sixteen parts of water was 
then added to the Choorna. This entire mixture was 
then boiled till 1/4th part remained. This mixture was 
then filtered using a cotton cloth to get Kwatha.  
One part of Kalka of Bala and Bilva was then 
taken to which four parts of Goghrita and sixteen parts 
of the above Kwatha were added. This entire mixture 
was then boiled till Sneha or Ghrita only left behind. 
While the Sneha Paka, the Baladi Ghrita at 
Mridu Paka stage should be collected for Nasya. The 
Lakshanas of Mridu Paka were then observed like the 
Kalka being sticky on touch as it contained traces of 
water and it produced crackling sound when kept on 
fire. This Ghrita was then used for Nasya purpose. 
Method 
Inclusion Criteria  
 Patients between the age group of 08to 60yrs 
were selected. 
 Patients presenting with the classical features of 
Nasapratinaha (Hypertrophic Turbinates). 
 Patients were selected irrespective of sex, 
occupation, religion, socio – economic status and 
duration of illness. 
Exclusion Criteria 
 Patients below 08 years and above 60 years of 
age were excluded. 
 Patients suffering with Nasapratinaha other than 
Hypertrophic Turbinates like DNS, Polyps and 
those with other systemic and neurological 
problems. 
 Duration of the disease more than one year. 
Assessment Criteria 
Subjective Parameters 
1. Nasal Obstruction 
2. Nasal Discharge 
3. Loss of Smell Perception 
4. Discomfort in Nose 
5. Congestion of Nasal Mucosa and Turbinates 
6. Headache 
Objective Parameters 
1. Anterior Rhinoscopy 
2. X-Ray (PNS) 
Investigations: X-ray, PNS view 
Research Design: Patients were divided into 2 groups. 
i.e., Group A and Group B. 
Group A: Baladi Ghrita Nasya was administered for 
seven days, once daily in the morning.  
Group B: Nasya with Goghrita for seven days was 
administered, once daily in the morning. 
 After seven days of treatment, both the 
groups were followed at regular intervals of 15 days for 
a period of two months. Following method was adopted 
for administration of Navana Nasya.  
Method of Navana Nasya 
Purvakarma: The Purvakarma of Nasya was performed 
in a place having sufficient light and devoid of direct 
blowing winds and dust. Patient was asked to sleep 
comfortably in supine position on a table and Abhyanga 
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with lukewarm Taila was done over face, scalp, 
temporal and neck region. After completion of 
Abhyanga, Mrudusvedana was done by covering the 
eyes.  
Pradhanakarma: After Purvakarma, the patient was 
asked to relax and lie down on a table in supine 
position and head portion was made to extend further 
from the edge of table bending at an angle. The limbs 
were kept slightly up and spread apart on both the 
sides. Baladi Ghrita Nasya/Goghrita was taken over on a 
piece of cloth/by a cotton swab respectively, and six 
drops are administered in each nostril. Thereafter 
patient was asked to inhale deeply and was advised to 
spit it out the drug that reaches the throat.  
Pashchatkarma: After performing the Nasya Karma, 
patient was allowed to come to ease in supine position. 
Again massage and fomentation with palms were done 
around face, nose, head, neck and chin. It was advised 
to spit out nasal secretion reaching the throat and to do 
gargle with warm water. After this, the patient was 
given instructions neither to take cold food and water 
nor to have a cold water face wash and to avoid wind, 
sun and dust.  
Follow up study: After the completion of treatment, all 
the patients were advised to attend the O.P.D up to two 
months for the follow up study. 
Criteria for assessment of treatment 
Assessment of treatment were made before and after the 
treatment based on,  
1. Nasal obstruction 
2. Nasal discharge  
3. Loss of Smell Perception 
4. Discomfort in Nose 
5. Congestion of Nasal Mucosa and Turbinates 
6. Headache  
7. X – ray, PNS view 
Gradation Index Showing Gradation Index 
Sl. No. Assessment criteria 
1.  Nasal blockage  
 0 – Not present 
 1 – Slight nasal obstruction but no mouth breathing 
 2 – Partial nasal obstruction with occasional mouth breathing 
 3 – Gross nasal obstruction with mouth breathing 
 4 – Total nasal obstruction with mouth breath/day 
2.  Nasal Discharge 
 0 – No discharge 
 1 – Negligible 
 2 – Intermittent 
 3 – Continuous 
 4 – Heavy 
3.  Reduced Smell Perception 
 0 – No  
 1 – Occasional  
 2 – Partial 
 3 – Complete 
4.  Discomfort in Nose 
 0 – Not present 
 1 – Slight discomfort 
 2 – Intermittent discomfort 
 3 – Continuous discomfort 
 4 – Severe discomfort 
5.  Congested Nasal Mucosa and Turbinates 
 0 – No  
 1 – Congestion of nasal mucosa 
 2 --Congestion of nasal mucosa & turbinates 
 3 – Hypertrophy of mucosa & turbinates 
 4 – Congestion, Oedema & obstructive lesions  
6.  Headache 
 0 – No 
 1 – Occasional 
 2 – Intermittent 
 3 – Continuous 
 4 – Intolerable 
Objective X-Ray (PNS): 0- Normal 
                          1- Hazy 
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Before Treatment Grading 
0 – Nil 
1 – Mild  
2 – Moderate 
3 – Severe 
4 – Very Severe 
After Treatment 
4– No Relief 
3 – Mild Relief 
2 – Moderate Relief 
1 – Good Relief  
0 – Complete Relief 
Severity of Nasapratinaha  
For assessing the severity of Nasapratinaha in 
each patient the above adopted scores were grouped 
and assessed as follows  
Absent  - 0 -  0 
Mild   -1 -  1- 4score 
Moderate  -2 -  4- 8 Score 
Severe  - 3 -  8-12 Score 
Very Severe   - 4- >12 Score 
For assessing the relief observed in the various 
severity of Nasapratinaha, the above adopted scores 
were assessed as follows: 
Complete Relief -  0  
Good Relief -   1-4 score 
Moderate Relief- 4-8 score 
Mild Relief-  8-12 score 
No Relief-  >12  
No change in score and score within one group 
was considered as No relief, change of score from one 
group to the immediate next was considered as Mild 
Relief, difference of two groups was considered as 
Moderate Relief, that of three Good and difference of 
four groups was considered as Complete Relief. 
Statistical analysis of the Result 
The results having P value less than < 0.05 is 
considered as statistically significant in this study. 
Criteria for Assessment of Overall Symptoms 
Overall effect of the therapies was assessed in 
terms of complete remission, marked improvement, 
moderate improvement, and mild improvement. 
Complete remission: 100% relief in complaints is 
considered as complete remission. 
Marked improvement: More than 70% and less than 
100% improvements in complaints is recorded as 
marked improvement. 
Moderate improvement: 70% and more than 50% 
improvement in complaints is recorded as moderate 
improvement. 
Mild improvement: 50% and more than 20% 
improvement in chief complaints is considered as mild 
improvement. 
Not responded/ unchanged: Less than 20% reduction 
in complaints or recurrence of the symptoms to the 
similar extent of severity is noted as recurrence. 
Follow up study: After the completion of treatment, all 
the patients are advised to attend the O.P.D up to three 
months for the follow up study with a regular interval 
of 15 days. 
Recurrence: Less than 20% reduction in chief 
complaints or recurrence of the symptoms to the 
similar extent of severity is noted as recurrence. 
Observations and Results 
Observations 
20 patients of Nasapratinaha (Hypertrophic 
Turbinates) were taken for the clinical trial, with 10 
patients divided in two groups. One was given Nasya 
with Baladi Ghrita and the second with plain Goghrita. 
The observation made in the present study is as 
follows. 
Results 
Nasal Obstruction 
Severity of Nasal Obstruction: Severity of Nasal 
Obstruction was recorded as per the history given by 
the patients. Data was graded according to gradation 
index. Statistical analysis is made on the basis of data, 
collected before and after treatment. 
Table 1: Showing the ‘t’ test results of the difference between the means of the two dependent samples (before 
and after treatment) in reduction of severity of the Nasal Obstruction in Group A and Group B 
Obstruction  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days of 
treatment 
2.4 1.0 1.4 58.33 0.97 0.31 9 4.58 <0.005 
Follow up after 1 
month 
2.4 1.2 1.2 50.00 0.14 0.36 9 3.34 <0.01 
Follow up after 2 
month  
2.4 1.4 1.0 41.66 1.05 0.33 9 3.00 <0.025 
G 
R 
After 7 days of 
treatment 
2.8 2.1 0.7 25.00 0.67 0.21 9 3.28 <0.010 
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O 
U 
P  
B 
Follow up after 1 
month 
2.8 2.2 0.6 21.42 0.70 0.22 9 2.71 <0.025 
Follow up after 2 
month  
2.8 2.4 0.4 14.28 0.70 0.22 9 1.81 >0.05 
In group A, the reduction in mean severity of the Nasal Obstruction is 
 Before and after treatment shows changes from 2.4 to 1.0 showing a reduction of 1.4 (58.33%) which is 
statistically significant at the level of p<0.005,  
 Changes after 1st month follow up is from 2.4 to 1.2 showing a reduction of 1.2 (50%) which is statistically 
significant at the level of p<0.01 and  
 Changes after 2nd month follow up is from 2.4 to 1.4 showing a reduction of 1.0 (41.66%) which is statistically 
significant at the level of P <0.025. 
In group B, the reduction in mean severity of the Nasal Obstruction is 
 Before and after treatment shows changes from 2.8 to 2.1 showing a reduction of 0.7 (25%) which is 
statistically significant at the level of P <0.010. 
 Changes after 1st month follow up is from 2.8 to 2.2 showing a reduction of 0.6 (21.42%) which is statistically 
significant at the level of P <0.025 and  
 Changes after 2nd month follow up is from 2.8 to 2.4 showing a reduction of 0.4 (14.28%) which is statistically 
insignificant at the level of P >0.05. 
Nasal Discharge 
The symptom of nasal discharge was recorded according to the gradation index. Data was collected and statistically 
analysed.  
Table 2: Showing the ‘t’ test results of the difference between the means of the two dependent samples 
(before and after treatment) in reduction of Nasal discharge in Group A and Group B 
Nasal discharge  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days 
of treatment 
2.2 0.9 1.3 59.09 0.82 0.26 9 4.99 <0.001 
Follow up 
after 1 month 
2.2 1.2 1.0 45.45 0.67 0.21 9 4.74 <0.005 
Follow up 
after 2 month  
2.2 1.1 1.1 50.00 1.10 0.35 9 3.16 <0.025 
G 
R 
O 
U 
P  
B 
After 7 days 
of treatment 
2.3 1.7 0.6 15.00 0.84 0.27 9 2.25 >0.05 
Follow up 
after 1 month 
2.3 1.7 0.6 15.00 0.52 0.16 9 3.67 <0.01 
Follow up 
after 2 month  
2.3 2.2 0.1 -10.00 0.74 0.23 9 0.43 >0.05 
In group A, the mean reduction of nasal discharge is 
 Before and after treatment shows changes from 2.2 to 0.9 showing a reduction of 1.3 (59.09%) which is 
statistically significant at the level of p <0.001. 
 Changes after 1st month follow up is from 2.2 to 1.2 showing a reduction of 1.0 (45.45%) which is statistically 
significant at the level of p <0.005. 
 Changes after 2nd month follow up is from 2.2 to 1.1 showing a reduction of 1.1 (50%) which is statistically 
significant at the level of p <0.025. 
In group B, the mean reduction of nasal discharge is 
 Before and after treatment shows changes from 2.3 to 1.7 showing a reduction of 0.6 (15%) which is 
statistically insignificant at the level of p >0.05. 
 Changes after 1st month follow up is from 2.3 to 1.7 showing a reduction of 0.6(15%) which is statistically 
significant at the level of p <0.01 and  
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 Changes after 2nd month follow up is from 2.3 to 2.1 showing a reduction of 0.1 (-10%) which is statistically 
insignificant at the level of p >0.05. 
Smell Perception: The symptom of smell perception was recorded according to the gradation index. Data was 
collected and statistically analysed. 
Table 3: Showing the ‘t’ test results of the difference between the means of the two dependent samples (before 
and after treatment) in reduction of loss of smell perception in Group A and Group B 
Smell Perception  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days 
of treatment 
0.7 0.4 0.3 42.85 0.67 0.21 9 1.41 >0.05 
Follow up 
after 1 month 
0.7 0.4 0.3 42.85 0.67 0.21 9 1.41 >0.05 
Follow up 
after 2 month  
0.7 0.4 0.3 42.85 0.48 0.15 9 1.96 >0.05 
G 
R 
O 
U 
P  
B 
After 7 days 
of treatment 
0.8 0.6 0.2 25.00 0.79 0.25 9 0.80 >0.05 
Follow up 
after 1 month 
0.8 0.6 0.2 25.00 0.79 0.25 9 0.80 >0.05 
Follow up 
after 2 month  
0.8 0.6 0.2 25.00 0.42 0.13 9 1.50 >0.05 
In group A, the mean reduction of loss of smell perception is 
 Before and after treatment shows changes from 0.7 to 0.4 showing a reduction of 0.3 (42.85%) which is 
statistically insignificant at the level of P >0.05.  
 Changes after 1st month follow up is from 0.7 to 0.4 showing a reduction of 0.3 (42.85%) which is statistically 
insignificant at the level of P >0.05 and  
 Changes after 2nd month follow up is from 0.7 to 0.4 showing a reduction of 0.3 (42.85%) which is statistically 
insignificant at the level of P >0.05. 
In group B, the mean reduction of loss of smell perception is 
 Before and after treatment shows changes from 0.8 to 0.6 showing a reduction of 0.2 (25%) which is statistically 
insignificant at the level of P >0.05. 
 Changes after 1st month follow up is from 0.8 to 0.6 showing a reduction of 0.2 (25%) which is statistically 
insignificant at the level of P >0.05 and  
 Changes after 2nd month follow up is from 0.8 to 0.6 showing a reduction of 0.2 (25%) which is statistically 
insignificant at the level of P >0.05. 
Headache: The symptom of headache was recorded according to the gradation index. Data was collected and 
statistically analysed. 
Table 4: Showing the ‘t’ test results of difference between the means of two dependent samples (before and 
after treatment) in reduction of headache, of Group A and Group B 
Headache Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df ‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days 
of treatment 
1.1 0.6 0.5 54.54 0.53 0.17 9 3.00 <0.025 
Follow up 
after 1 month 
1.1 0.3 0.8 27.27 0.79 0.25 9 3.21 <0.025 
Follow up 
after 2 month  
1.1 0.4 0.7 36.36 0.48 0.15 9 4.58 <0.005 
G 
R 
O 
U 
P  
B 
After 7 days 
of treatment 
0.7 0.3 0.4 57.14 0.70 0.22 9 1.81 >0.05 
Follow up 
after 1 month 
0.7 0.3 0.4 57.14 0.52 0.16 9 2.45 <0.05 
Follow up 
after 2 month  
0.7 0.3 0.4 57.14 0.70 0.22 9 1.81 >0.05 
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In group A, the mean reduction of headache is 
 Before and after treatment shows changes from 1.1 to 0.6 showing a reduction of 0.5 (57.14%) which is 
statistically significant at the level of P >0.025.  
 Changes after 1st month follow up is from 1.1 to 0.3 showing a reduction of 0.8 (27.27%) which is statistically 
significant at the level of P <0.025 and  
 Changes after 2nd month follow up is from 1.1 to 0.4 showing a reduction of 0.7 (36.36%) which is statistically 
significant at the level of P <0.005. 
In group B, the mean reduction of headache is 
 Before and after treatment shows changes from 0.7 to 0.3 showing a reduction of 0.4 (57.14%) which is 
statistically insignificant at the level of P >0.05. 
 Changes after 1st month follow up is from 0.7 to 0.3 showing a reduction of 0.4 (57.14%) which is statistically 
significant at the level of P <0.05 and  
 Changes after 2nd month follow up is from 0.7 to 0.3 showing a reduction of 0.4 (57.14%) which is statistically 
insignificant at the level of P >0.05. 
Discomfort of Nose: The symptom of discomfort in nose was recorded according to the gradation index. Data 
was collected and statistically analysed.  
Table 5: Showing the ‘t’ test results of the difference between the means of the two dependent samples (before 
and after treatment) in reduction in discomfort of nose in Group A and Group B 
Discomfort of Nose  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days of 
treatment 
1.1 0.5 0.6 54.54 0.70 0.22 9 2.71 <0.025 
Follow up 
after 1 month 
1.1 0.6 0.5 45.45 0.53 0.17 9 3.00 <0.025 
Follow up 
after 2 month  
1.1 0.5 0.6 54.54 0.84 0.27 9 2.25 >0.05 
G 
R 
O 
U 
P  
B 
After 7 days of 
treatment 
1.9 1.3 0.6 31.57 1.07 0.34 9 1.77 >0.05 
Follow up 
after 1 month 
1.9 1.3 0.6 31.57 0.97 0.31 9 1.96 >0.05 
Follow up 
after 2 month  
1.9 1.2 0.7 36.84 1.34 0.42 9 1.66 >0.05 
In group A, the mean reduction of discomfort of nose is 
 Before and after treatment shows changes from 1.1 to 0.5 showing a reduction of 0.6 (54.54%) which is 
statistically significant at the level of P <0.025.  
 Changes after 1st month follow up is from 1.1 to 0.6 showing a reduction of 0.5 (45.45%) which is statistically 
significant at the level of P <0.025 and  
 Changes after 2nd month follow up is from 1.1 to 0.5 showing a reduction of 0.6 (54.54%) which is statistically 
insignificant at the level of P >0.05. 
In group B, the mean reduction of discomfort of nose is 
 Before and after treatment shows changes from 1.9 to 1.3 showing a reduction of 0.6 (31.57%) which is 
statistically insignificant at the level of P >0.05. 
 Changes after 1st month follow up is from 1.9 to 1.3 showing a reduction of 0.6 (31.57%) which is statistically 
insignificant at the level of P >0.05 and  
 Changes after 2nd month follow up is from 1.9 to 1.2 showing a reduction of 0.7 (36.84%) which is statistically 
insignificant at the level of P >0.05. 
Congestion of Nasal Mucosa and Turbinates 
The symptom of congestion of nasal mucosa and turbinates was recorded according to the gradation index. Data 
was collected and statistically analysed.  
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Table 6: Showing the ‘t’ test results of the difference between the means of the two dependent samples (before and after 
treatment) in reduction of congestion of nasal mucosa and turbinates in Group A and Group B 
Congestion  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days 
of treatment 
2.1 1.1 1.0 47.61 0.82 0.26 9 3.87 <0.005 
Follow up 
after 1 month 
2.1 1.3 0.8 38.09 0.79 0.25 9 3.21 <0.025 
Follow up 
after 2 month  
2.1 1.5 0.6 28.57 0.70 0.22 9 2.71 <0.025 
G 
R 
O 
U 
P  
B 
After 7 days 
of treatment 
2.2 1.9 0.3 13.63 0.82 0.26 9 1.15 >0.05 
Follow up 
after 1 month 
2.2 1.5 0.7 31.81 0.67 0.21 9 3.28 <0.01 
Follow up 
after 2 month  
2.2 1.9 0.3 13.63 0.82 0.26 9 1.15 >0.05 
In group A, the mean reduction of nasal congestion is 
 Before and after treatment shows changes from 2.1 to 1.1 showing a reduction of 1.0 (47.61%) which is 
statistically significant at the level of P <0.005. 
 Changes after 1st month follow up is from 2.1 to 1.3 showing a reduction of 0.8 (38.09%) which is statistically 
significant at the level of P <0.025 and  
 Changes after 2nd month follow up is from 2.1 to 1.5 showing a reduction of 0.6 (28.57%) which is statistically 
significant at the level of P <0.025. 
In group B, the mean reduction of nasal congestion is 
 Before and after treatment shows changes from 2.2 to 1.9 showing a reduction of 0.3 (13.63%) which is 
statistically insignificant at the level of P >0.05. 
 Changes after 1st month follow up is from 2.2 to 1.5 showing a reduction of 0.7 (31.81%) which is statistically 
significant at the level of P <0.01 and  
 Changes after 2nd month follow up is from 2.2 to 1.9 showing a reduction of 0.3 (13.63%) which is statistically 
insignificant at the level of P >0.05. 
X – Ray Findings: X – Ray findings were and gradation was done according gradation index. Statistical analysis was 
made with before and after treatment data. 
Table 7: Shows the ‘t’ test results of the difference between the means of the two dependent samples (before 
and after treatment) in X – ray findings of Group A and Group B 
X – ray findings  
Mean score Reduction in 
mean score 
% of reduction 
in mean score 
S.D of 
mean 
S.E of 
mean 
df 
‘t’ 
Value 
‘p’ 
Value BT AT 
G 
R 
O 
U 
P  
A 
After 7 days 
of treatment 
0.9 0.5 0.4 44.44 0.52 0.16 9 2.45 <0.05 
Follow up 
after 1 month 
0.9 0.7 0.2 22.22 0.63 0.20 9 1.00 >0.05 
Follow up 
after 2 month  
0.9 0.7 0.2 22.22 0.63 0.20 9 1.00 >0.05 
G 
R 
O 
U 
P  
B 
After 7 days 
of treatment 
0.8 0.6 0.2 25.00 0.42 0.13 9 1.50 >0.05 
Follow up 
after 1 month 
0.8 0.7 0.1 12.50 0.32 0.10 9 1.00 >0.05 
Follow up 
after 2 month  
0.8 0.7 0.1 12.50 0.32 0.10 9 1.00 >0.05 
In group A, the mean reduction in X – Ray findings 
 Before and after treatment shows changes from 0.9 to 0.5 showing a reduction of 0.4 (44.44%) which is 
statistically significant at the level of P <0.05.  
 Changes after 1st month follow up is from 0.9 to 0.7 showing a reduction of 0.2 (22.22%) which is statistically 
insignificant at the level of P >0.05 and  
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 Changes after 2nd month follow up are from 0.9 to 0.7 showing a reduction of 0.2 (22.22%) which is 
statistically insignificant at the level of P> 0.05. 
In group B, the mean reduction in X – Ray findings 
 Before and after treatment shows changes from 0.8 to 0.6 showing a reduction of 0.2 (25%) which is 
statistically insignificant at the level of P >0.05. 
 Changes after 1st month follow up is from 0.8 to 0.7 showing a reduction of 0.1 (12.50%) which is statistically 
insignificant at the level of P >0.05 and  
 Changes after 2nd month follow up is from 0.8 to 0.7 showing a reduction of 0.1 (12.50%) which is statistically 
insignificant at the level of P >0.05. 
Thus in all the above five parameters of assessment, the percentage of improvement / relief can be made out as 
follows. 
Table 8: Percentage of improvement / relief in the symptoms of Nasapratinaha in Group A and B after 
treatment (i.e. after 7 days of treatment) 
G 
R 
O 
U 
P\A 
Severity of Disease Number of Patients Relief 
  Complete Good Moderate Mild No 
Mild - - - - - - 
Moderate - - - - - - 
Severe 07 01 00 03 03 00 
Very Severe 03 00 00 01 01 01 
G 
R 
O 
U 
P\B 
Mild - - - - - - 
Moderate 01 00 00 00 00 01 
Severe 04 00 00 00 02 02 
Very Severe 05 00 00 00 05 00 
Table 9: Patients of Group A and Group B after 7 days of Nasya Karma 
Percentage of improvement / relief Group A Group B 
Reduction in severity of Nasal Obstruction  58.33% 25.00% 
Reduction in nasal discharge 59.09% 15.00% 
Reduction in smell perception 42.85% 25.00% 
Reduction in headache 54.54% 57.14% 
Reduction in Discomfort of Nose 54.54% 31.51% 
Reduction in Congestion 47.61% 13.51% 
Changes in X-Ray Finding 44.44% 25.00% 
Table 10: Showing of improvement/Relief in each symptom of Group A 
Symptoms Group A-Relief in Symptoms 
No of Pts Complete Marked Moderate Mild No Increase  
Nasal Obstruction 10 04 00 02 02 02 00 
Nasal Discharge 10 04 00 00 05 01 00 
Smell Perception 05 01 00 01 00 03 00 
Headache 08 02 00 00 03 03 00 
Discomfort in Nose 07 04 00 00 01 02 00 
Congestion 10 02 00 01 04 03 00 
Table 11: Showing of improvement/Relief in each symptom of Group B 
Symptoms Group B- Relief 
in Symptoms 
      
No of Pts Complete Marked Moderate Mild No Increase  
Nasal Obstruction 10 00 00 01 05 04 00 
Nasal Discharge 10 01 00 00 05 03 01 
Smell Perception 06 02 00 00 00 03 01 
Headache 07 05 00 00 00 01 01 
Discomfort in Nose 09 01 00 01 05 01 01 
Congestion 10 00 00 01 02 06 01 
Mayur V.Shiralkar et al. Comparative Study of Baladi Ghrita Nasya with Goghrita Nasya in the Management of Nasapratinaha 
 Available online at : http://ijapr.in  86 
Table 12: Showing over all percentage of improvement / relief in the patients of Group A and Group B 
Overall improvement / 
relief 
No. of Patients in 
Group A 
Percentage % 
No. of Patients 
in Group B 
Percentage 
% 
Complete remission 01 10% 00 00% 
Marked relief 03 30% 00 00% 
Moderate relief 03 30% 00 00% 
Mild relief 02 20% 06 60% 
Not responding 01 10% 04 40% 
Out of 10 patients of Group A, 01 (10%) had 
complete relief, 03 (30%) had marked relief, 03 (30%) 
had moderate relief, 02 (20%) had mild relief and 01 
(10%) did not respond to treatment. In Group B, 06 
(60%) had mild relief and 04 (40%) did not respond to 
the treatment. 
From the above data it is clear that Baladi Ghrita is 
useful in managing Nasapratinaha. 
DISCUSSION 
Nasapratinaha is one among the 31 types of 
Nasa Rogas. The main symptom of which is Nasal 
Obstruction. As per contemporary science, various 
conditions lead to nasal obstruction like DNS, Polyps, 
Hypertrophic Turbinates, Atrophic Rhinitis, Choanal 
Atresia etc. In the present study Nasal Obstruction due 
to Hypertrophic Turbinates is only taken.  
Discussion on distribution of Age: Patients were 
randomly categorized into two groups. Of which, the 
first group of patients were given Baladi Ghrita Nasya 
and in second group Nasya with Goghrita was given. An 
observation of present study reveals that maximum 
numbers of patient’s i.e. 55% were between the age 
group of 16 - 30 years. This is the age group of college 
going in whom chances of exposure to allergens is 
more, hence may be the cause for high incidence. The 
minimum age of the patient registered for the study 
was 10 years old and maximum was 45 years old. 
Discussion on distribution of Sex: It was observed 
that more numbers of patients were males i.e. 60% and 
40% were females. This might be because males are 
more exposed to the environment than the females. 
Discussion on distribution of Religion: Maximum 
number of patients belonged to Hindu community. This 
might be because Hindu’s residing here are more in 
number. Hence, has no research significance. 
Discussion on distribution of Socio-Economic 
Status: Socio-economic status wise distribution of 
patients in this study noted that Nasapratinaha was 
more prevalent (45%) in upper class than in the middle 
class (30%) and lower class (25%). This may be 
because of prolonged and over use of sweet, freezed 
and preserved items which may cause cold leading to 
the hypertrophy of turbinates. This might be the reason 
for high incidence in the upper class than the middle 
and lower class. 
Discussion on distribution of Habitat: Habitat wise 
distribution revealed that majority of the patients 
included in the study were from Urban area (70%) than 
that from the Rural area (30%). This supports the fact 
that as patients from urban area have more exposure to 
air pollution, than that of rural area, hence the 
incidence of Nasapratinaha is more in the Urban 
population.  
Discussion on distribution as per Prakruti: Prakruti 
wise distribution shows that maximum number of 
patients included in the study were of Vatakaphaja 
Prakruti (40%) than Kaphapittaja (30%), Vatapittaja 
(15%) and Pittakaphaja prakruti (15%). As Vata Dosha 
and Kapha Dosha are the main Doshas in 
Nasapratinaha, the disease is more prevalent in 
Vatakaphaja prakruti as per the present study.  
Discussion on Dietary Habitat Dietary Habitat wise 
distribution has revealed more number of patients 
being mixed (55%) than that of pure vegetarian (45%). 
There is not much of difference in ratio of percentage 
between the two groups. Hence has no significance in 
the current study. 
Discussion on Occupation: The chief occupations of 
the patients noted in this study were, students (55%), 
agriculturist (15%), housewives (10%), businessmen 
(10%), nursing (5%) and teacher (5%). Occupation 
wise distribution noted that, Nasapratinaha was 
prevalent in those who were studying in schools and 
colleges and those working in fields. Both these groups 
are exposed to dust, wind and extreme atmospheric 
conditions. By these, we can infer that working 
environment (occupation) plays an important role in 
causing Nasapratinaha.  
Discussion on Nidana: Most of the Nidana described in 
the classics were observed in patients with 
Nasapratinaha. Especially Nidana like Avashyaya 
(45%), Raja Sevana (70%), Dhooma sevana (70%), 
Ambukrida (10%), Pratishyaya (20%) were reported. 
These can act either as an Utpadaka or as a Vyanjaka 
nidana for Nasapratinaha. In this study, in addition to 
the above etiological factors, it is noted that in few of 
the patients Pratishayaya (20%) acted as a 
Nidhanakara roga or predisposing factor in the 
manifestation of Nasapratinaha.  
Discussion on Lakshanas: It is observed that, nasal 
obstruction is present in all patients (100%) nasal 
obstruction aggravated when exposed to air and dust, 
this can be clearly justified as this is a part of Samprapti 
mentioned in the classics.  
Discussion on severity of Nasal Obstruction: The 
incidence of severity of nasal obstruction showed that 
10% of patients experienced very severe nasal 
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obstruction, 45% suffered with severe degree of nasal 
obstruction, 40% with moderate and 5% with mild 
form of nasal obstruction. The above proves that nasal 
obstruction is present in 100% patients.  
Discussion on severity of Nasal Discharge: The 
incidence of severity of nasal discharge showed that 
35% suffered with severe degree of nasal discharge, 
55% with moderate and 10% with mild form of nasal 
discharge. This is because the turbinates, when 
inflamed, partially block the opening of the sinuses into 
the middle meatus leading to stagnation of secretion 
into the sinuses. This stagnated secretion comes out in 
the form of discharge through the nose. Asatmya 
Gandha and Sheeta Sevana are also responsible for 
nasal discharge. 
Discussion on Severity of Loss of Smell Perception: 
The incidence of severity of loss of smell perception 
showed that 05% of patients suffered from severe loss 
of smell perception, 10% with moderate and 40% with 
mild loss of smell perception, whereas 45% of patients 
did not complain of any kind of loss of smell perception. 
This shows that smell perception is not a common 
feature seen in Nasapratinaha with respect to 
Hypertrophic Turbinates. The possible reason for loss 
in smell perception can be that because of hypertrophic 
turbinates, inspired air is not able to reach the roof of 
nose where the olfactory receptors are situated. Hence 
the patient dose not gets smell perception properly. In 
45% of patients in the present study, the inflammation 
of turbinates was not gross hence loss of smell 
perception was not complained by them. 
Discussion on Severity of Headache: The incidence of 
severity of headache showed that 15% of patients 
suffered from moderate form of headache, 55% 
suffered from mild form and 30% did not complain of 
any kind of headache at all. This shows that headache is 
also not a common feature of Nasapratinaha with 
respect to Hypertrophic Turbinates. Majority of the 
sinuses drain into the middle meatus. The inflamed 
turbinates block the drainage of these sinuses into the 
middle meatus. This leads to mild form of sinusitis 
which might be the possible explanation for the 
predominance of mild (55%) form of headache. The 
Udana Vayu in this condition gets encircled by vitiated 
Kapha dosha and leads to Nasapratinaha with 
Shirashoola. 
Discussion on severity of Discomfort in Nose: The 
incidence of severity of discomfort in nose showed that 
5% of patients suffered from very severe form of nasal 
discomfort, 15% showed severe form, 30% moderate, 
25% mild and 25% of patients did not complain of any 
kind of discomfort. Obstruction in nose leads to some 
kind of discomfort to the patient. This discomfort is 
dependant on the amount of obstruction and range of 
Dosha vitiation experienced by the patient as he or she 
is not able to breath air normally. In the present study, 
15% had gross obstruction hence they experienced 
severe discomfort, 30% had moderate obstruction 
hence they experienced moderate discomfort, 25% had 
mild obstruction hence they experienced mild 
discomfort and 25% had negligible obstruction hence 
no discomfort was observed in them. 
Discussion on severity of Congestion of Nasal 
Mucosa and Turbinates: The incidence of severity of 
Congestion of Nasal Mucosa and Turbinates revealed 
25% of patients had severe form of congestion, 65% 
had moderate and 10% had mild form of congestion. 
Congestion is one of the main reasons for nasal 
obstruction. In Hypertrophic Turbinates, the turbinate 
gets congested and inflamed causing an obstruction in 
nasal pathway. Hence even in the current study, 65% of 
patients showed moderate form of congestion whereas 
there was not a single patient who did not present with 
any form of congestion of nasal mucosa and turbinates. 
Discussion on properties of Drug and its role in 
Samprapti Vighatana: Baladi Ghrita was administered 
as Nasya in Group A. The contents in it are Bala, Bilva 
and Goghrita. In group B, Nasya with pure Goghrita was 
administered. Both Baladi Ghrita and Goghrita were 
observed as non irritant, as none of the patients 
complained of any adverse effect or irritation. Bala is of 
Madhura Rasa, Sheeta Veerya and Madhura Vipaka. It 
has the properties such as Balya, Brumhana, Anulomana 
and is Vatahara. Bala with its Madhura Rasa, Sheeta 
Veerya and Madhura Vipaka helps in the Shamana of 
Vata Dosha. It also has got Balya and Brumhana 
properties which helps in Vata Shamana. With its 
Anulomana Guna, it helps the Pratilomit Vata Dosha to 
return to its normal route and function. The chemical 
composition of Bala (Sida Cordifolia) is Ephidrine. 
Ephidrine is an alpha adrenergic drug. This alpha 
agonist on topical application as dilute solution 
produces local vasoconstriction. This vasoconstriction 
helps in relieving the nasal congestion and thus helps in 
relieving nasal obstruction. Bilva is of Kashaya Tikta 
Rasa, Ushna veerya and Katu vipaka. It has properties 
such as Shothahara, Grahi and Kaphaghna. In 
Nasapratinaha, the main Doshas involved are Udana 
Vayu and Kapha dosha. Bilva with its Kashaya Tikta 
Rasa, Ushna Veerya and Katu Vipaka is good Kaphagna 
and helps in reducing Kapha Avarana. It also posses the 
properties like Shothahara, which helps in relieving the 
inflammation of turbinates. With its Kaphaghna and 
Grahi gunas, Bilva helps in scraping out the excessive 
Kapha that has enveloped (Avarana) Udana Vayu and 
thus help in bringing the nose back to its normal 
function. Properties of Goghrita as per classics are 
Madhura rasa, Sheeta veerya, Madhura vipaka and Vata 
pitta shamaka. Goghrita has the capacity to transform 
itself so as to imbibe all the qualities of the substances. 
It is particularly significant that ghee does not give up 
its own properties even if it mixed up with other 
substances possessing other properties. In the 
procedure of Nasya karma, the procedures such as 
Snehana and Swedana constitute the Poorva karma; 
these have the properties such as Dosha viliyana, 
Jadyahara, Sthabdagna and Ruk prashamana. The 
Pradhana karma constitute, administration of the drug 
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to Nasa, they act on their own accord depending on the 
properties of the drug in them. In Paschat karma 
Mardhana and Panitapa sweda are done repeatedly and 
Ushna kavala is done to remove the residual Dosha or 
drug. As per the above classical description of the 
drugs, it is doubtless that Baladi Ghrita is having 
Vatakaphahara, Brumhana, Vatanulomana, Shothahara, 
Snehana, Kanduhara, Sravahara properties hence is 
capable to remove the Kapha Avarana Vata Shamana 
and promote Vata Svamarga Pravrutti thus capable to 
control Nasapratinaha. In contemporary science, 
primary management of hypertrophic turbinates is 
steam inhalation and instillation of local decongestant 
drops. These procedures help in relieving the 
congestion in nose and thus help in relieving the patient 
from nasal obstruction. Thus, the above mentioned 
drugs and the procedures have the properties to cheek 
the pathology as per Ayurveda in Nasapratinaha and 
also in terms of contemporary science for Hypertrophic 
Turbinates.  
Discussion on Results 
Nasal Obstruction: Nasal blockage is observed in all 
the 20 patients of group A and Group B. Relief from 
nasal blockage after treatment is 58.33% and 25.00% 
in group A and group B respectively. (P values at the 
level of <0.005 and <0.10 respectively). The relief of 
nasal obstruction after treatment noted was more 
significant in Group A than Group B. It suggests that 
Baladi Ghrita is more effective than normal Goghrita. 
At the end of second month of follow up, it was 
observed that among the 10 patients in group A, 02 had 
complete relief, 01 had moderate relief and 05 patients 
had mild relief, 01 patient had no relief and in 01 
patient the symptom aggravated. 
 In group B, after 2 months of follow up among 10 
patients, 05 patients had mild relief, 04 patents had no 
relief and in 01 patient the symptom aggravated.  
The above description shows that the effect of Baladi 
Ghrita in group A shows more improvement than that 
of Goghrita in group B. 
Nasal Discharge: Nasal discharge is observed in all the 
20 patients of group A and Group B. Relief from nasal 
discharge after treatment is 59.09% and 15%. in group 
A and group B respectively. (‘p’ values at the level of 
<0.001 and >0.05 respectively). The relief of nasal 
discharge after treatment noted was more significant in 
Group A and insignificant in Group B. It suggests that 
Baladi Ghrita is more effective than normal Goghrita in 
controlling nasal discharge. At the end of second month 
follow up, it was observed that among 10 patients in 
group A, 03 had complete relief, 01 had moderate relief 
and 04 patients had mild relief, 01 patient showed no 
relief and in 01 patient the symptom had aggravated.  
In group B among 10 patients, 03 patients had mild 
relief, 05 patients had no relief in their symptoms and 
in 02 patients the symptoms had aggravated. It shows 
that, the response to the treatment is poor in group B 
than group A. This shows that Baladi Ghrita is effective 
in controlling the discharge in Nasapratinaha. 
Loss of Smell Perception: Loss of smell perception 
was observed in 05 patients of group A and 06 patients 
of group B. Relief from Loss of smell perception after 
treatment was 42.85% and 25% in group A and group 
B respectively. (P values at the level of >0.05 in both the 
groups). The relief of loss of smell perception after 
treatment noted was insignificant in both the groups. It 
shows that the loss of smell perception has not much 
responded to the treatment in both the groups but 
slight improvement is noted after two months of follow 
up. 
At the end of second month follow up, it was observed 
that among 05 patients of group A, 02 had complete 
relief, 01 patient had mild relief and in 02 patients 
there was no relief.  
In group B among 06 patients, 02 patients had mild 
relief and 04 patients had no relief.  
It shows that, both groups have no marked relief in loss 
of smell perception after the treatment.  
Severity of Headache: Headache was observed in 08 
patients of group A and 06 patients of group B. Relief 
from headache after treatment was 92.95% % and 
73.07% in group A and group B respectively. (P values 
at the level of <0.001 in both the groups). The relief of 
headache after treatment noted was significant in both 
the groups. It suggests that both Baladi Ghrita and 
Goghrita are effective in managing headache in 
Nasapratinaha with respect to Hypertrophic 
Turbinates. 
At the end of second month follow up, it was observed 
that among 08 patients in group A, 04 had complete 
relief, 03 patients had mild relief and in 01 patient 
there was no relief.  
In group B among 06 patients, 05 had complete relief, 
01 patient had no relief and in 01 patient the symptom 
began after second month of follow up.  
It shows that, Baladi Ghrita Nasya is found effective at 
the time of follow up than the period of medication. 
Discomfort in Nose: Discomfort was observed in 07 
patients of group A and 08 patients of group B. Relief 
from discomfort after treatment was 54.54% % and 
31.57% in group A and group B respectively. (P values 
at the level of <0.025 and >0.05 in group A and B 
respectively). The relief of discomfort after treatment 
noted was significant in group A and insignificant in 
group B. It suggests that Baladi Ghrita is effective in 
managing discomfort of nose than Goghrita in 
Nasapratinaha with respect to Hypertrophic 
Turbinates.  
At the end of second month follow up, it was 
observed that among 07 patients in group A, 04 had 
complete relief, 02 patients had mild relief, 01 patient 
no relief and in 01 patient the symptom started at the 
end of second month. In group B among 08 patients, 01 
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had complete relief, 01 patient had good relief, 04 
patients had mild relief, 02 patients had no relief and in 
01 patient the symptom began at the end of second 
follow up. This shows that Baladi Ghrita is effective in 
controlling discomfort in nose better than Goghrita. 
Congestion of Nasal Mucosa and Turbinates 
Congestion of Nasal Mucosa and Turbinates 
was observed in all the patients of group A and group B. 
Relief from Congestion of Nasal Mucosa and Turbinates 
after treatment was 47.61% % and 13.63% in group A 
and group B respectively. (P values at the level of 
<0.005 and >0.05 in group A and B respectively). The 
relief of Congestion of Nasal Mucosa and Turbinates 
after treatment noted was significant in group A and 
insignificant in group B. It suggests that Baladi Ghrita is 
effective in managing Congestion of Nasal Mucosa and 
Turbinates than Goghrita in Nasapratinaha with 
respect to Hypertrophic Turbinates. 
At the end of second month of follow up, it was 
observed that among 10 patients of group A, 01 had 
moderate relief, 04 patients had mild relief and in 05 
patients there was no relief.  
In group B among 10 patients, 05 patients had 
mild relief, 03 patients had no relief and in 02 patients 
the symptom had aggravated. This shows that Baladi 
Ghrita is effective in controlling congestion of nasal 
mucosa and turbinates better than Goghrita 
X – Ray findings: Shadow of turbinates was positive in 
09 patients in group A and 08 patients in group B. After 
the treatment shadows of turbinates were reduced by 
44.44% and 25.00% in group A and B respectively. (P 
values at the level of <0.05and >0.05 in group A and B 
respectively). The relief after treatment noted was 
significant in group A and insignificant in group B. It 
suggests that Baladi Ghrita is effective than Goghrita in 
reducing the disease (turbinates shadow) in 
Nasapratinaha with respect to Hypertrophic 
Turbinates. 
At the end of second month of follow up, among 09 
patients in group A, 03 had clear X – Ray findings 
(responded to treatment), 06 had no change (not 
responded to treatment) in their X-Ray pattern, and in 
01 patient the X-Ray showed shadows of turbinates 
(previously clear X-Ray) by the end of second month. 
Among 08 patients of group B, 01 had clear X-Ray 
findings (responded to treatment) and 07 had no 
change in their X-Ray pattern (not responded to 
treatment).  
As per the above data, it is clear that the improvement / 
relief was better in the patients of group A, who were 
treated with Baladi Ghrita Nasya and there is significant 
reduction in the severity of nasal obstruction, nasal 
discharge, headache, congestion. In Group B patients, 
who were administered Nasya with Goghrita, showed a 
minimal improvement / relief in nasal obstruction, 
headache, congestion after seven days of Nasya. After 
second month of follow up Group A showed a 
significant relief in obstruction, discharge, headache 
and congestion of nasal mucosa and turbinates. In 
Group B instead of responding to treatment showed 
aggravation of all symptoms after second month and no 
significant relief was found. 
Discussion on Range of Severity of Symptoms 
In Group A, among 10 patients 
1. 07 (70%) patients had severe form of 
Nasapratinaha of which 01 (10%) patient got 
complete relief, 03 (30%) got moderate and 03 
(30%) got mild relief. 
2.  03 (30%) of patients had very severe form of 
Nasapratinaha in whom 01 (10%) got moderate 
relief, 01 (10%) got mild and 01 (10%) got no relief 
from symptoms. 
Of the 10 patients of Group B 
1. 01 (10%) had moderate form of Nasapratinaha 
who got no relief from his symptoms,  
2. 04 (40%) had severe form of the disease among 
whom 02 (20%) got mild relief and 02 (20%) had 
no relief from symptoms and  
3. 05 (50%) had very severe form of disease among 
whom all got mild relief from symptoms. 
From the above result we can conclude that in 
the present study Baladi Ghrita Nasya was effective in 
different forms of Nasapratinaha. 
In group A the percentage of relief is improved 
after 2 months of follow up, but in group B the 
percentage of relief is further decreased after two 
months of follow up. 
It is therefore concluded that Baladi Ghrita 
Nasya has an effective role in treating Nasapratinaha 
than Nasya with plain Goghrita.  
CONCLUSION 
 Nidana explained in Ayurvedic classics seems to be 
initiating or precipitating factor for Nasapratinaha. 
Vihara sambhandi nidana like exposure to dust 
(raja), smoke (Dhooma), cold breeze (Sheetavayu) 
and Nidanarthakara roga like Pratishyaya have a 
significant role causing Nasapratinaha. 
 Samprapti of Nasapratinaha is complex, as various 
known, unknown, exogenous, or endogenous 
etiological factors are involved in the pathological 
process. 
 In the present study, the prevalence of 
Nasapratinaha is more in males than females. 
 Family history is insignificant in causing 
Nasapratinaha.  
 Baladi Ghrita Nasya is effective than Goghrita in 
reliving the severity of disease. 
 Nasya with Goghrita showed mild 
improvement/relief from the symptoms but nearly 
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all the symptoms aggravated again during follow 
up. 
 By comparing both the groups, Group A patients 
those who were administered Baladi Ghrita Nasya 
showed a significant improvement / relief in the 
management of Nasapratinaha.  
 Hence the efficacy of Baladi Ghrita Nasya in the 
management of Nasapratinaha is proved effective. 
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